Form 8-K - Current report:
SEC Accession No. 0001789769-23-000018
Filing Date
2023-01-27
Accepted
2023-01-27 17:00:31
Documents
12
Period of Report
2023-01-24
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K til-20230124.htm   iXBRL 8-K 41885
  Complete submission text file 0001789769-23-000018.txt   182683

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT til-20230124.xsd EX-101.SCH 1890
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT til-20230124_lab.xml EX-101.LAB 24831
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT til-20230124_pre.xml EX-101.PRE 13036
6 EXTRACTED XBRL INSTANCE DOCUMENT til-20230124_htm.xml XML 11685
Mailing Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219 (972) 499-3350
Instil Bio, Inc. (Filer) CIK: 0001789769 (see all company filings)

EIN.: 832072195 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40215 | Film No.: 23564039
SIC: 2836 Biological Products, (No Diagnostic Substances)